A carregar...

Maintaining remission in ulcerative colitis – role of once daily extended-release mesalamine

The aminosalicylates (5-ASA; also referred to as mesalamine-based agents) are considered as first-line in the maintenance of remission of mild to moderate ulcerative colitis (UC). Traditionally these agents have required a large pill burden and multiple daily dosing regimens which may account for th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Oliveira, Lilliana, Cohen, Russell D
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3063115/
https://ncbi.nlm.nih.gov/pubmed/21448448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S5392
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!